Rare diseases
Investigational molecules
Locations
Skaftahlid 24, 105 Reykjavik, Iceland
Landspitali supports clinical research in multiple myeloma and smoldering multiple myeloma, with attention to both intermediate-risk and high-risk disease. Its research activity includes evaluation of treatment strategies aimed at disease control and deeper response in patients with plasma cell malignancies.
These studies reflect a focus on blood cancer management within a hospital-based clinical research setting in Iceland.
Landspitali runs clinical trials in conditions such as Dyspepsia, Plasma cell myeloma, among others.
Clinical trials registered by this sponsor – none is enrolling right now.
Comparing 7-Day and 4-Week Esomeprazole Treatment in Patients with Unexplained Dyspepsia
IcelandStudy on Treating Smoldering and Active Multiple Myeloma with Dexamethasone, Lenalidomide, and Carfilzomib for Patients in Iceland
IcelandIncrease visibility for your trials and help patients find your site through our platform.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
